|
PFSCF
|
FDA PDUFA date for Pg has to come soon, any day now, and that could well...
|
|
PFSCF
|
Based on the track record, additional debt financing from Thomvest could be...
|
|
PFSCF
|
Hey XXX Since we last talked about PLI, the company has submitted its BLA...
|
|
PFSCF
|
Pl talks about it at every webcast. The clinical trial pathway is clear...
|
|
PFSCF
|
Stag, you seem not to have any idea of the Pg story at PLi and how it...
|
|
PFSCF
|
The Swedishb trials are not way off. According to either the MS or Cantor...
|
|
PFSCF
|
Thanks, Mario. Very interesting. Might take a partnership deal plus a voucher...
|
|
PFSCF
|
So barcode, based on your analysis, I am thinking that the FDA decision on a...
|
|
PFSCF
|
Thanks, Dibah. Much appreciated:-)
|
|
PFSCF
|
Someone thru Scotia just bought a big chunk of shares. Probably a result of...
|
|
PFSCF
|
Thanks, Dibah. Much appreciated!
|
|
PFSCF
|
Given that CTAs will be sought in Japan, Europe, Canada and Australia, PLI...
|
|
PFSCF
|
I expect to see some partnership deals by the end of the year now that the...
|
|
PFSCF
|
Thanks, 33. looking forward to it:-)
|
|
PFSCF
|
Biofinder, you raise a very good point. If your jump off date is 2020 then it...
|
|
PFSCF
|
Scotia has laid out the bet in clear terms. If PLI can raise $75M from...
|
|
PFSCF
|
About 1200 people have been diagnosed with AS. perhaps a market of $50M+ So...
|
|
PFSCF
|
If I understand correctly there are only 85 AS patients in the UK so the 4050...
|
|
PFSCF
|
Brillant results. AS application of 4050 has promising innovative medicine...
|
|
PFSCF
|
I think you are right, bio finder. First authorised use of 4050 will likely...
|